Focuslight Technologies Inc. (688167.SH)'s application for a private placement of shares has been accepted by the Shanghai Stock Exchange.
Focuslight Technologies Inc. (688167.SH) announced that on November 4, 2026, the Company received the "Notice on Accepting the Application for Securities Issuance by a STAR Market Listed Company of Xi'an Focuslight Technologies Inc." (SSE STAR Review (Refinancing) [2026] No. 256) issued by the Shanghai Stock Exchange (hereinafter referred to as the "SSE"). In accordance with relevant regulations, the SSE reviewed the prospectus and related application documents for securities issuance by a STAR Market listed company submitted by the Company, and determined that the application documents are complete and comply with statutory requirements. The SSE decided to accept the application and conduct review in accordance with the law.
Focuslight Technologies Inc. (688167.SH) announced that on November 4, 2026, the Company received the "Notice on Accepting the Application for Securities Issuance by a STAR Market Listed Company of Xi'an Focuslight Technologies Inc." (SSE STAR Review (Refinancing) [2026] No. 256) issued by the Shanghai Stock Exchange (hereinafter referred to as the "SSE"). In accordance with relevant regulations, the SSE reviewed the prospectus and related application documents for securities issuance by the STAR Market listed company submitted by the Company, and determined that the application documents are complete and comply with the statutory format. The SSE decided to accept the application and conduct review in accordance with the law.
Related Articles
US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) rose more than 6% as Apple Inc.'s intelligence features for the China market began testing, opening new opportunities for Qwen.
KPA-BM HLDGS (02663) changes controlling shareholder, receives a general offer at a discount of approximately 13.8%, trading resumes on November 5.
MICOT PHARMA-B (02335) received the first project funding under the National Science and Technology Major Project and obtained ethics approval from the lead site for the Phase III clinical trial of MT200605.
US Stock Market Move | Alibaba Group Holding Limited Sponsored ADR (BABA.US) rose more than 6% as Apple Inc.'s intelligence features for the China market began testing, opening new opportunities for Qwen.
KPA-BM HLDGS (02663) changes controlling shareholder, receives a general offer at a discount of approximately 13.8%, trading resumes on November 5.
MICOT PHARMA-B (02335) received the first project funding under the National Science and Technology Major Project and obtained ethics approval from the lead site for the Phase III clinical trial of MT200605.
